Skip to main content
. 2018 Dec 20;2018(12):CD007964. doi: 10.1002/14651858.CD007964.pub2

Tarrier 1999.

Methods Allocation: randomised
 Blinding: assessor
Location: National Health Service trusts in Greater Manchester
Lenght of follow‐up: 24 months
Participants Diagnosis: schizophrenia, schizoaffective psychosis, delusional disorder (DSM‐III R)
 N = 87
Sex: 69 M, 18 F
Age: mean ˜ 39 years, SD ˜ 11 years
 Included: length of illness: median ˜ 11 years; experiencing psychotic symptoms (i.e. hallucinations or delusions) for at least six months which did not appear to be responding further to medication; no evidence of organic pathology which could have explained the psychopathology; ages 16 ‐ 65 years; receiving regular and stable antipsychotic medication
Excluded: not reported
Interventions 1. CBT group*: N = 33
Content: coping strategy enhancement, training in problem‐solving, strategies to reduce relapse
Delivered by: three experienced clinical psychologists and followed a protocol manual
Frequency: six hourly sessions, each of which were followed by two summary sessions. Sessions were carried out twice a week and 20 sessions of treatment were carried out over ten weeks. Four booster sessions were given once a month for four months.
Treatment duration: 10 weeks
2. Standard care group: N = 28
Content: standard psychiatric management with medication, monitoring outpatient follow‐up and care programme approach
Delivered by: not reported
Frequency: not reported
Treatment duration: 10 weeks
Outcomes Global state: relapse
Mental state: clinically important change (no improvement)**, negative symptoms (SANS)
Adverse event: death (any cause)
 Satisfaction with treatment: leaving the study early
Unable to use:
 Mental state: positive symptoms ‐ (log transformed data) calculated by combining PSE and BPRS scores (data not in the format suitable for analysis and we were unable to convert it)
Notes *Participants in the CBT group also received the standard care intervention.
**defined as not achieved 50% improvement in psychotic symptoms in both severity and number of symptoms
We did not use the data from a third arm where the intervention was supportive counselling plus standard care (n = 26).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "...generated by the Institute for Medical Biometry using a computerized algorithm and was stored by CenTrial." (p.S102)
Comments: The investigators described a random component in the sequence generation process.
Allocation concealment (selection bias) Low risk Quote: "...generated by the Institute for Medical Biometry using a computerized algorithm and was stored by CenTrial." (p.S102)
Comments: The allocation assignment were conducted centrally.
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Quote: "The therapist then gives the information about treatment allocation to the patient." (p.S102)
Comments: Participants and therapists knew the allocation assignment.
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Quote: "...assessor blind regarding the study condition..." "...the result of the randomisation only to the therapist in order to keep the assessor blind regarding the study condition." (p.S102)
Comments: blinding of outcome assessment ensured
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Comments: 26 participants dropped out from the trial at 2‐year follow‐up, however, the intention‐to‐treat sample included all randomised participants.
Selective reporting (reporting bias) Low risk Comments: All measured outcome were reported.
Other bias Low risk Funding source: This study was funded publicly by the German Research Foundation (Deutsche Forschungsgemeinschaft, grants Kl 1179/2‐1 and Kl 1179/3‐1).
Comments: none obvious